AAPL327.36+0.77 (+0.23%) ▲|ABBV255.33+1.95 (+0.77%) ▲|ABT100.05-1.61 (-1.58%) ▼|ACN140.89-3.84 (-2.65%) ▼|ADBE226.71-8.03 (-3.42%) ▼|AMAT567.75+42.05 (+8.00%) ▲|AMD541.70+38.13 (+7.57%) ▲|AMGN364.49+0.32 (+0.09%) ▲|AMT163.75-3.32 (-1.98%) ▼|AMZN248.49-1.51 (-0.60%) ▼|AVGO386.17+8.01 (+2.12%) ▲|AXP351.03-0.90 (-0.26%) ▼|BA204.31-5.18 (-2.47%) ▼|BAC61.30+0.88 (+1.45%) ▲|BKNG177.97-1.48 (-0.82%) ▼|BLK1,040.96-13.15 (-1.25%) ▼|BMY60.47+0.31 (+0.51%) ▲|BNY158.67+1.74 (+1.11%) ▲|BRK-B489.69-1.56 (-0.32%) ▼|C132.90+4.18 (+3.25%) ▲|CAT889.71+25.41 (+2.94%) ▲|CL90.08-1.86 (-2.02%) ▼|CMCSA23.78-0.01 (-0.02%) ▼|COF206.12-0.65 (-0.31%) ▼|COP117.06+1.38 (+1.19%) ▲|COST931.02-4.78 (-0.51%) ▼|CRM170.24-3.55 (-2.04%) ▼|CSCO111.37+0.67 (+0.61%) ▲|CVS109.60+1.99 (+1.85%) ▲|CVX189.98+0.27 (+0.14%) ▲|DE589.47+3.47 (+0.59%) ▲|DHR178.69-22.42 (-11.15%) ▼|DIS96.50+0.09 (+0.09%) ▲|DUK125.59-0.26 (-0.21%) ▼|EMR139.43+2.85 (+2.09%) ▲|FDX314.80+8.58 (+2.80%) ▲|GD369.90-0.70 (-0.19%) ▼|GE340.98-0.33 (-0.10%) ▼|GEV1,083.23+4.05 (+0.38%) ▲|GILD129.80-3.41 (-2.56%) ▼|GM79.64+3.84 (+5.07%) ▲|GOOG348.19-3.18 (-0.91%) ▼|GOOGL348.89-3.10 (-0.88%) ▼|GS1,082.40+27.37 (+2.59%) ▲|HD330.63-2.41 (-0.72%) ▼|HON230.23+4.05 (+1.79%) ▲|IBM211.29-1.71 (-0.80%) ▼|INTC105.07+8.01 (+8.25%) ▲|INTU290.07-3.76 (-1.28%) ▼|ISRG357.26+4.09 (+1.16%) ▲|JNJ249.27+0.45 (+0.18%) ▲|JPM344.88+6.01 (+1.77%) ▲|KO82.09-0.04 (-0.04%) ▼|LIN506.73-5.32 (-1.04%) ▼|LLY1,163.31+16.41 (+1.43%) ▲|LMT505.40-4.14 (-0.81%) ▼|LOW203.42-1.29 (-0.63%) ▼|LRCX320.97+14.21 (+4.63%) ▲|MA538.78-8.66 (-1.58%) ▼|MCD265.19-2.45 (-0.92%) ▼|MDLZ59.79-0.49 (-0.80%) ▼|MDT82.31-0.98 (-1.18%) ▼|META647.02+1.17 (+0.18%) ▲|MMM169.90+10.79 (+6.78%) ▲|MO73.31-1.36 (-1.81%) ▼|MRK125.69+1.29 (+1.04%) ▲|MS215.36+4.42 (+2.10%) ▲|MSFT398.61-3.68 (-0.91%) ▼|MU974.66+109.20 (+12.62%) ▲|NEE87.92-0.08 (-0.09%) ▼|NFLX67.46-0.15 (-0.21%) ▼|NKE43.11-0.37 (-0.84%) ▼|NOW101.47-3.24 (-3.09%) ▼|NVDA206.09+2.81 (+1.38%) ▲|ORCL126.60+5.22 (+4.30%) ▲|PEP134.75-0.71 (-0.52%) ▼|PFE24.86+0.11 (+0.42%) ▲|PG147.65-1.49 (-1.00%) ▼|PLTR132.86-1.99 (-1.48%) ▼|PM189.68-3.04 (-1.58%) ▼|QCOM172.97+2.65 (+1.55%) ▲|RTX194.98+0.54 (+0.28%) ▲|SBUX104.48-0.33 (-0.31%) ▼|SCHW100.69-1.85 (-1.80%) ▼|SO93.68-0.78 (-0.83%) ▼|SPG226.54-1.65 (-0.72%) ▼|T22.09+0.14 (+0.62%) ▲|TMO523.98-2.25 (-0.43%) ▼|TMUS191.72-3.92 (-2.00%) ▼|TSLA380.14+10.57 (+2.86%) ▲|TXN293.49+9.42 (+3.32%) ▲|UBER71.53-0.65 (-0.89%) ▼|UNH434.26+12.71 (+3.02%) ▲|UNP294.41-1.85 (-0.62%) ▼|UPS115.91+2.76 (+2.43%) ▲|USB63.35+0.21 (+0.32%) ▲|V356.82-3.76 (-1.04%) ▼|VZ43.47-0.03 (-0.07%) ▼|WFC87.96+1.63 (+1.89%) ▲|WMT110.46-1.74 (-1.55%) ▼|XOM150.90+2.54 (+1.71%) ▲|AAPL327.36+0.77 (+0.23%) ▲|ABBV255.33+1.95 (+0.77%) ▲|ABT100.05-1.61 (-1.58%) ▼|ACN140.89-3.84 (-2.65%) ▼|ADBE226.71-8.03 (-3.42%) ▼|AMAT567.75+42.05 (+8.00%) ▲|AMD541.70+38.13 (+7.57%) ▲|AMGN364.49+0.32 (+0.09%) ▲|AMT163.75-3.32 (-1.98%) ▼|AMZN248.49-1.51 (-0.60%) ▼|AVGO386.17+8.01 (+2.12%) ▲|AXP351.03-0.90 (-0.26%) ▼|BA204.31-5.18 (-2.47%) ▼|BAC61.30+0.88 (+1.45%) ▲|BKNG177.97-1.48 (-0.82%) ▼|BLK1,040.96-13.15 (-1.25%) ▼|BMY60.47+0.31 (+0.51%) ▲|BNY158.67+1.74 (+1.11%) ▲|BRK-B489.69-1.56 (-0.32%) ▼|C132.90+4.18 (+3.25%) ▲|CAT889.71+25.41 (+2.94%) ▲|CL90.08-1.86 (-2.02%) ▼|CMCSA23.78-0.01 (-0.02%) ▼|COF206.12-0.65 (-0.31%) ▼|COP117.06+1.38 (+1.19%) ▲|COST931.02-4.78 (-0.51%) ▼|CRM170.24-3.55 (-2.04%) ▼|CSCO111.37+0.67 (+0.61%) ▲|CVS109.60+1.99 (+1.85%) ▲|CVX189.98+0.27 (+0.14%) ▲|DE589.47+3.47 (+0.59%) ▲|DHR178.69-22.42 (-11.15%) ▼|DIS96.50+0.09 (+0.09%) ▲|DUK125.59-0.26 (-0.21%) ▼|EMR139.43+2.85 (+2.09%) ▲|FDX314.80+8.58 (+2.80%) ▲|GD369.90-0.70 (-0.19%) ▼|GE340.98-0.33 (-0.10%) ▼|GEV1,083.23+4.05 (+0.38%) ▲|GILD129.80-3.41 (-2.56%) ▼|GM79.64+3.84 (+5.07%) ▲|GOOG348.19-3.18 (-0.91%) ▼|GOOGL348.89-3.10 (-0.88%) ▼|GS1,082.40+27.37 (+2.59%) ▲|HD330.63-2.41 (-0.72%) ▼|HON230.23+4.05 (+1.79%) ▲|IBM211.29-1.71 (-0.80%) ▼|INTC105.07+8.01 (+8.25%) ▲|INTU290.07-3.76 (-1.28%) ▼|ISRG357.26+4.09 (+1.16%) ▲|JNJ249.27+0.45 (+0.18%) ▲|JPM344.88+6.01 (+1.77%) ▲|KO82.09-0.04 (-0.04%) ▼|LIN506.73-5.32 (-1.04%) ▼|LLY1,163.31+16.41 (+1.43%) ▲|LMT505.40-4.14 (-0.81%) ▼|LOW203.42-1.29 (-0.63%) ▼|LRCX320.97+14.21 (+4.63%) ▲|MA538.78-8.66 (-1.58%) ▼|MCD265.19-2.45 (-0.92%) ▼|MDLZ59.79-0.49 (-0.80%) ▼|MDT82.31-0.98 (-1.18%) ▼|META647.02+1.17 (+0.18%) ▲|MMM169.90+10.79 (+6.78%) ▲|MO73.31-1.36 (-1.81%) ▼|MRK125.69+1.29 (+1.04%) ▲|MS215.36+4.42 (+2.10%) ▲|MSFT398.61-3.68 (-0.91%) ▼|MU974.66+109.20 (+12.62%) ▲|NEE87.92-0.08 (-0.09%) ▼|NFLX67.46-0.15 (-0.21%) ▼|NKE43.11-0.37 (-0.84%) ▼|NOW101.47-3.24 (-3.09%) ▼|NVDA206.09+2.81 (+1.38%) ▲|ORCL126.60+5.22 (+4.30%) ▲|PEP134.75-0.71 (-0.52%) ▼|PFE24.86+0.11 (+0.42%) ▲|PG147.65-1.49 (-1.00%) ▼|PLTR132.86-1.99 (-1.48%) ▼|PM189.68-3.04 (-1.58%) ▼|QCOM172.97+2.65 (+1.55%) ▲|RTX194.98+0.54 (+0.28%) ▲|SBUX104.48-0.33 (-0.31%) ▼|SCHW100.69-1.85 (-1.80%) ▼|SO93.68-0.78 (-0.83%) ▼|SPG226.54-1.65 (-0.72%) ▼|T22.09+0.14 (+0.62%) ▲|TMO523.98-2.25 (-0.43%) ▼|TMUS191.72-3.92 (-2.00%) ▼|TSLA380.14+10.57 (+2.86%) ▲|TXN293.49+9.42 (+3.32%) ▲|UBER71.53-0.65 (-0.89%) ▼|UNH434.26+12.71 (+3.02%) ▲|UNP294.41-1.85 (-0.62%) ▼|UPS115.91+2.76 (+2.43%) ▲|USB63.35+0.21 (+0.32%) ▲|V356.82-3.76 (-1.04%) ▼|VZ43.47-0.03 (-0.07%) ▼|WFC87.96+1.63 (+1.89%) ▲|WMT110.46-1.74 (-1.55%) ▼|XOM150.90+2.54 (+1.71%) ▲|
27.4 C
New York
Tuesday, July 21, 2026

Tag: tissue repair

newssourceFORcompanyinformationcontent1releasesmarket

Longeveron Granted Small or Medium-sized Enterprise (SME) Status by the European Medicines Agency (EMA)

Longeveron (LGVN) granted Small or Medium-sized Enterprise (SME) status by the European Medicines Agency (EMA).

Provectus Biopharmaceuticals Announces Investor Webinar for 2026 Annual Meeting of Stockholders

KNOXVILLE, Tenn., June 08, 2026 (GLOBE NEWSWIRE) -- Provectus Biopharmaceuticals, Inc. (“Provectus” or the “Company”) (OTCQB: PVCT) today announced that its 2026 annual stockholder meeting (the “Annual Meeting”), including shareholder meeting activities and a company update, will be accessible by Zoom webinar (the “Webinar”). The in-person meeting will be held on Thursday, June 18, 2026 at Perkins Place Office Building, located at 525 Portland Street, Knoxville, Tenn., beginning at 4:00 p.m. Eastern Time.

MISOORA Unveils Revolutionary K-Beauty Skincare Range Emphasizing Longevity Over Anti-Aging

A five-step biotech regimen, anchored by NAD+ and Retinaldehyde, opens its founding waitlist ahead of a June 22 US debut. 
A five-step biotech regimen, anchored by NAD+ and Retinaldehyde, opens its founding waitlist ahead of a June 22 US debut.

Surrozen Reports Second Quarter 2025 Financial Results and Provides Business Update

Surrozen Reports Second Quarter 2025 Financial Results and Provides Business Update

Longeveron Announces Up To $17.5 Million Public Offering

Longeveron announces the pricing of a public offering of common stock and warrants.

Interstitial Cystitis Market to Grow Rapidly at a CAGR of 4% During the Study Period (2020-2034) | DelveInsight

The interstitial cystitis market is limited by a few approved treatments and high unmet need. However, pipeline innovation and rising awareness are expected to...

Interstitial Cystitis Market to Grow Rapidly at a CAGR of 4% During the Study Period (2020-2034) | DelveInsight

The interstitial cystitis market is limited by a few approved treatments and high unmet need. However, pipeline innovation and rising awareness are expected to...

Collagen Supplement Trends in 2025: Why Pilly Labs Collagen Gummies Are Leading the Natural Glow-Up Movement

As consumer demand for clean beauty and functional supplements rises in 2025, marine collagen gummies like Pilly Labs are emerging as a preferred daily solution for supporting skin texture, joint mobility, and hair strength — all without powders, pills, or synthetic additives. 
As consumer demand for clean beauty and functional supplements rises in 2025, marine collagen gummies like Pilly Labs are emerging as a preferred daily solution for supporting skin texture, joint mobility, and hair strength — all without powders, pills, or synthetic additives.

iCRYO Adds Dr. Jason Sonners to Medical Advisory Board, Strengthens Commitment to Safe, Effective Hyperbaric Oxygen Therapy

HOUSTON, July 28, 2025 /PRNewswire/ -- iCRYO, a leading health, wellness, and longevity franchise, is proud to announce the appointment of Dr. Jason Sonners,...

Biosurgery Market worth US$21.59 Billion by 2030 with 6.4% CAGR | MarketsandMarkets™

DELRAY BEACH, Fla., July 28, 2025 /PRNewswire/ -- The global Biosurgery Market, valued at US$14.96 billion in 2024 stood at US$15.83 billion in 2025 and...

Biosurgery Market worth US$21.59 Billion by 2030 with 6.4% CAGR | MarketsandMarkets™

DELRAY BEACH, Fla., July 28, 2025 /PRNewswire/ -- The global Biosurgery Market, valued at US$14.96 billion in 2024 stood at US$15.83 billion in 2025 and...

Citryll Announces Formation of Scientific Advisory Board

CITRYLL ANNOUNCES FORMATION OF SCIENTIFIC ADVISORY BOARD

Longeveron® Announces U.S. FDA Approval of IND Application for a Phase 2 Pivotal Registration Study Evaluating Laromestrocel as a Treatment of Pediatric Dilated Cardiomyopathy...

FDA approves Longeveron's Investigational New Drug (IND) application for stem cell therapy as a potential treatment for pediatric dilated cardiomyopathy.

Longeveron® to Participate in the H.C. Wainwright 6th Annual Neuro Perspectives Hybrid Conference

Longeveron CEO Wa’el Hashad will present at the H.C. Wainwright 6th Annual Neuro Perspectives Hybrid Conference.

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsTissue repair

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers